AI assistant
Sending…
CYTOKINETICS INC — Director's Dealing 2025
Oct 27, 2025
30870_dirs_2025-10-27_ae4da0f3-9fc1-4c5f-8fe9-7a87076492f8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2025-10-27
Reporting Person: WIERENGA WENDELL (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-10-27 | Common Stock | M | 4375 | $10.00 | Acquired | 36819 | Direct |
| 2025-10-27 | Common Stock | S | 4375 | $58.68 | Disposed | 32444 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-10-27 | Non-Qualified Stock Option (Right to Buy) | $10.00 | M | 4375 | Disposed | 2026-01-04 | Common Stock (4375) | Direct |
Footnotes
F1: This option shall vest and become exercisable as to 4,375 shares divided into equal monthly installments such that the option shall be 100% vested on January 4, 2017.
More from CYTOKINETICS INC
Share Issue/Capital Change
2026
May 27
Declaration of Voting Results & Voting Rights Announcements
2026
May 27
Share Issue/Capital Change
2026
May 7
Report Publication Announcement
2026
May 5
Annual Report
2026
Apr 17
Proxy Solicitation & Information Statement
2026
Apr 17
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18